FL
Approved in
relapsed FL after 2
systemic therapies

ZYDELIG®
Patient Profile

Consider ZYDELIG for patients with relapsed FL
after 2 prior therapies

Patient With Prior R-CVP, Followed by R Maintenance and BR
relapsed follicular lymphoma (FL) patient relapsed follicular lymphoma (FL) patient

Profile and photo are representative of patients in clinical trials but are not actual cases. For illustrative purposes only.

History

History

  • 62-year-old female
  • Takes metoprolol for hypertension

Diagnosis

Diagnosis

2007, grade 2 FL

Presentation

  • FLIPI score of 3
  • Ann Arbor stage IV
  • Normal hemoglobin level
  • Normal platelet count
  • Elevated ALC
  • Lymphadenopathy
  • Bone marrow involvement
  • ECOG performance status of 1

Prior
therapies

Prior therapies

At development of B symptoms

  • R-CVP, followed by R maintenance
  • BR

Current presentation

Current presentation

B symptoms have recurred

ALC=absolute lymphocyte count; BR=bendamustine, rituximab; ECOG=Eastern Cooperative Oncology Group; FL=follicular B-cell non-Hodgkin lymphoma; FLIPI=Follicular Lymphoma International Prognostic Index; R=rituximab; R-CVP=rituximab, cyclophosphamide, vincristine sulfate, prednisone.